Discontinuation of low-dose acetylsalicylic acid therapy in UK primary care: incidence and predictors in patients with cardiovascular disease

BACKGROUND: Discontinuation of low-dose acetylsalicylic acid (ASA) leads to an increased risk of cardiovascular and cerebrovascular events in patients taking low-dose ASA for secondary cardiovascular prevention. However, little is known about the rate of discontinuation in everyday clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Merino, Elisa, Johansson, Saga, Bueno, Héctor, García Rodríguez, Luis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045005/
https://www.ncbi.nlm.nih.gov/pubmed/27774013
http://dx.doi.org/10.2147/POR.S29557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045005/
https://www.ncbi.nlm.nih.gov/pubmed/27774013
http://dx.doi.org/10.2147/POR.S29557

Ejemplares similares